Living organism is an intelligent system encoded by hierarchically-organized information to 1 5 perform precisely-controlled biological functions. Biophysical models are important tools to 1 6 uncover the design rules underlying complex genetic-metabolic circuit interactions. Based on a 1 7 previously engineered synthetic malonyl-CoA switch (Xu et al, PNAS 2014), we have 1 8 formulated nine differential equations to unravel the design principles underlying an ideal 1 9 3 1 bidirectional ON-OFF gene expression control, which autonomously compensates enzyme level 3 2
Introduction 4 0
In recent years, there is an influx of applying dynamic control theory to optimize metabolic 4 1 pathways for production of various chemicals (Venayak, Anesiadis et al. 2015 , Xu 2018 , Xia, 1 0 0 2016). Malonyl-CoA is the essential metabolic building blocks for synthesizing advanced 1 0 1 biofuels (Xu, Gu et al. 2013) , lipids (Qiao, Wasylenko et al. 2017 , Xu, Qiao et al. 2017 ), 1 0 2 polyketides (Zhou, Qiao et al. 2010 , Liu, Marsafari et al. 2019 , oleochemicals (Xu, Qiao et al. level of malonyl-CoA benefits the production of these metabolites (Yang, Kim et al. 2018 ) but 1 0 5 also inhibits cell growth (Xu, Li et al. 2014 , Liu, Xiao et al. 2015 . Up to date, the FapR-derived 1 0 6 malonyl-CoA sensor has been successfully applied to mammalian cell (Ellis and Wolfgang 2012), 1 0 7 E. coli (Xu, Wang et al. 2014 , Yang, Kim et al. 2018 ) and yeast (Li, Si et al. 2015 , David, al. 2014) has garnered significant attractions and allows us to study the optimal configurations of 1 1 0 the controller architecture ( Fig. 1) . By integrating genetic and metabolic circuits, we have been 1 1 1 able to experimentally construct and validate a malonyl-CoA oscillatory switch that was 1 1 2 engineered to improve fatty acids production in E. coli (Xu, Li et al. 2014 ). Experimentally, we 1 1 3 have engineered malonyl-CoA-responsive promoters that could be upregulated or down- and feedback regulation that are naturally occurring in many bacteria. One essential question is how to effectively configure the regulatory architecture of the 1 2 0 metabolic source pathway and the metabolic sink pathway. To unravel the design principles 1 2 1 underlying the malonyl-CoA switch, we set about to establish a biophysical model (system of 1 2 2 ODE equations) and interrogated a broad range of parameter spaces, including the protein 1 2 3 degradation rate (D), malonyl-CoA inhibitory constant (1/K 1 ) and malonyl-CoA source pathway 1 2 4 induction rate (β 2 ). We also determined the optimal regulatory architecture for both the malonyl- CoA source pathway (ACCase) and the malonyl-CoA sink pathway (FAS), defined by the FapR- Hill cooperativity coefficient (n). Our aim in this work is to understand how autonomous 1 2 8 oscillation may contribute to optimal metabolite (fatty acids) production in strain engineering. The computational framework may facilitate us to design and engineer predictable genetic-1 3 0 metabolic switches, quest for the optimal controller architecture of the metabolic source/sink 1 3 1 pathways, as well as leverage autonomous oscillation as a powerful tool to engineer cell function. which consumes malonyl-CoA. The FapR bindings sites on the ACC operon is an upstream 1 3 8 activation sequence (UAS). The FapR binding sites on the FAS operon is the fapO operator. To simplify the biochemical and genetic events, we made eight assumptions to extract the basics 1 4 6 of the genetic-metabolic circuits ( Fig. 1) : (a) We assume the number of DNA binding sites, 1 4 7 specifically, FapO and UAS, far exceeds the number of transcriptional factor FapR in the system. biosynthesis could be lumped into one single reaction to forming fatty acids (FA) from malonyl- production rate which is proportional to the cell growth rate; and Eqn. 10 describes the mass 1 7 8 balance for glucose, accounting for the consumption rate due to cell growth and acetyl-CoA production. For all the mass balance equations (Eqn. 2 to Eqn. 10), we also considered the 1 8 0 dilution or degradation terms. Biomass and cell concentration in the feeding stream of the system 1 8 1
were designated as S 0 and X 0 . of ACC and quickly antagonize the resulting malonyl-CoA at t > 20.
4 7
Phase-plane represents the solution constraints between the interacting components, at different 
units of concentration) were investigated ( Fig. 5) . As expected, strong inhibition (K 1 = 0.10) will CoA dissociation constants (K 1 ) have been labelled with different color. Low dissociation inhibition constant (K 1 ) varying from 0.1 to 1.5. A specific trajectory for K 1 = 0.3 is added to the for both the growth-associated leaky expression (α 3 ) and the FapR-activated regulatory 3 3 5 expression (β 2 , p and K 4 ). In all our simulations, we assume stringent regulation and the leaky expression is negligible (α 2 = α 3 = 0.05). We will specifically investigate how the ACCase induction rate (β 2 ) and the FapR-UAS dissociation constant (K 4 ) impact the system dynamics 3 3 8 ( Fig. 8 and Fig. 9 ). ranging from 0.50 to 4.0 ( Fig. 8) . As the ACCase induction rate increases (β 2 ) from 0.50 to 4.0, fatty acids production ( Fig. 8) . For example, the fatty acids production is increased up to 2-fold induction rate (β 2 ) ( Fig. 8) , possibly due to the antagonist effect of malonyl-CoA. However, this quickly to reach its steady state (Fig. 8) . This result indicates that a high ACCase induction rate 3 5 5 (β 2 ) is essential for the proper function of the control scheme. As FapR is the activator for the ACC operon, and the DNA binding site for FapR is a UAS 3 5 7
(upstream activation sequence). We next investigated how the FapR-UAS dissociation constant 3 5 8 (K 4 ) impacts the system dynamics ( Fig. 9) . A smaller FapR-UAS dissociation constant (K 4 ) 3 5 9
indicates a tighter binding between FapR and UAS (the inverse of the dissociation constant 3 6 0 quantifies the binding affinity). As the binding between FapR and UAS becomes tighter (K 4 3 6 1 decreases from 8.0 to 1.0), the expression of the malonyl-CoA source pathway (ACCase) is 3 6 2 strongly activated, leading to increased fatty acids production ( Fig. 9) . For example, the fatty decreases from 8.0 (purple line, Fig. 9 ) to 1.0 (blue line, Fig. 9 ). Under high FapR-UAS binding amplitude. This result indicates that a tighter FapR-UAS binding is the critical factor to achieve 3 6 8
the desired control scheme. binding is advantageous to fatty acids production. Effect of FapR-fapO interaction on system dynamics 3 7 3
We also attempted to understand how the gene expression of the malonyl-CoA sink pathway 3 7 4 (FAS) impacts the system dynamics. By design, FapR is the repressor that is specifically bound 3 7 5
to fapO and represses the expression of the malonyl-CoA sink pathway (FAS). The system 3 7 6 equation for FAS (Eqn. 4) accounts for both the growth-associated leaky expression (α 2 ) and the 3 7 7
FapR-repressed regulatory expression (β 1 , n and K 3 ). Transcriptional factor (FapR) and DNA dissociation constant) and the Hill cooperativity coefficient. By probing the physiologically 3 8 0 accessible parameter space, we will investigate how the FapR-fapO dissociation constant (K 3 ) 3 8 1
impact the system dynamics ( Fig. 10) .
We investigated a number of FapR-fapO dissociation constant (K 3 ), spanning from 0.50 to 8.0 3 8 3 ( Fig. 10) . A smaller FapR-fapO dissociation constant indicates a tighter binding between FapR 3 8 4
and fapO, thus the FapR-fapO complex will function as a stronger roadblock to prevent FAS 3 8 5
transcription. As the binding between FapR and fapO becomes tighter (K 3 decreases from 8.0 to 3 8 6 0.5), the expression of the malonyl-CoA sink pathway (FAS) is strongly repressed (Fig. 10) ,
leading to decreased fatty acid accumulation. For example, the fatty acids production at low 3 8 8
FapR-fapO dissociation constant (K 3 = 0.50, blue curve) is less than 1/7 of the fatty acid 3 8 9
production at high FapR-fapO dissociation constant (K 3 = 8.0, green curve) ( Fig. 10) . With suggests that a weak binding between FapR and fapO (or a large FapR-fapO dissociation 3 9 6 constant) is the most important design criteria to achieve the desired ON-OFF control scheme. The Hill cooperativity coefficient is a critical factor determining the input-output relationship of will investigate how the FapR-FapO Hill cooperativity coefficient (n) impacts the system 4 0 7 dynamics ( Fig. 11) . We choose a number of FapR-fapO Hill cooperativity coefficients, ranging (FAS) and the malonyl-CoA source pathway (ACC), we could explore the 'optimal controller' 4 2 1 structure in this study (Fig. 1B) . Here we consider both positive Hill coefficients (n = 2.0 and 4.0) controller architecture that leads to maximal fatty acids production. repression (n = 4) leads to stable oscillation and drives the cell to make more fatty acids.
2 8
As the FapR-fapO Hill cooperativity coefficient (n) increases from -4.0 to 4.0, the regulatory repression. As a result, a significant increase in the FAS, ACCase expression and fatty acids 4 3 1 production are observed ( Fig. 11) . For example, almost 5-fold increase of fatty acids is obtained counterintuitively, the expression of FAS is instead downregulated (Fig. 11) . This could be With the better understanding of cellular regulation, metabolic engineers have been able to the models present in the current study were simple, they provide sufficient kinetic information 4 6 9
to predict the dynamic behavior of the published work. By interrogating the physiologically 4 7 0 accessible parameter space, we have determined the optimal control architecture to configure 4 7 1
both the malonyl-CoA source pathway and the malonyl-CoA sink pathway. We also investigated 4 7 2 a number of biological parameters that strongly impact the system dynamics, including the The fatty acids production could be increased from 50% to 10-folds with the different set of In this work, we have chosen a number of biophysical parameters to discuss the possible output here may facilitate us to design and engineer predictable genetic-metabolic switches, configure 4 9 0 the optimal controller architecture of the metabolic source/sink pathways, as well as reprogram Science Foundation under grant no.1805139 for funding support. Dr. Xu would also like to 4 9 5
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